Wei, L., Jia, J. D., Wang, F. S., Niu, J. Q., Zhao, X. M., Mu, S., Liang, L. W., Wang, Z., Hwang, P., Robertson, M. N., Ingravallo, P., Asante‐Appiah, E., Wei, B., Evans, B., Hanna, G. J., Talwani, R., Duan, Z. P., Zhdanov, K., Cheng, P., Tanwandee, T., Nguyen, V. K., Heo, J., Isakov, V., George, J., & , (2019). efficacy and safety of elbasvir/grazoprevir in participants with hepatitis C virus genotype 1, 4, or 6 infection from the Asia–Pacific region and Russia: Final results from the randomized C‐CORAL study. Journal of gastroenterology and hepatology, 34(1), 12–21. http://access.bl.uk/ark:/81055/vdc_100076809891.0x000045